Delivery Order SPE2DR25D1106-SPE2DR26FJK6B
- Not listed
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively bid delivery order by the Defense Logistics Agency on January 20, 2026, for 30 tablets of Entecavir 0.5 mg. The contract is valued at $4,300.51 with a completion date of January 21, 2026, and carries no set-aside designation. This delivery order was issued under Amerisourcebergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with the...
- AmerisourceBergen Drug Corp was awarded a delivery order on May 8, 2025, valued at $10,029.63 for the supply of Entecavir 0.5mg in quantities of 30 units. This firm fixed-price delivery order, funded by the Defense Logistics Agency's Medical Supply Chain division, is scheduled for completion by June 5, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania headquarters. The contract utilized competitive procurement procedures with no set-aside designation, reflecting...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,758.86 Firm Fixed Price Delivery Order is for the supply of 4564950562 - Entecavir 0.5 mg Tablet 30s, with a period of performance through June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Entecavir 0.5 mg tablets (30-count) valued at $3,383.40 under a firm fixed-price contract. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Entecavir 0.5 mg tablets in a quantity of 30 units, with a ceiling value of $1,267.02. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 12, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Entecavir 0.5 mg tablets in quantities of 30 units, with a ceiling value of $3,924.11 and a completion date of December 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and is performed at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Entecavir 0.5 mg tablets (30-count packages) with a ceiling value of $1,442.99. This is a firm fixed price delivery order with an ultimate completion date of December 9, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.21 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 29, 2026, performed at the awardee's facility in Conshohocken, Pennsylvania. Entecavir is an antiviral medication used to treat chronic hepatitis B infections. The delivery order represents a task order under AmerisourceBergen's larger...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Entecavir 0.5 mg tablets. The order has a ceiling value of $6,918.52 and a completion date of August 5, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $19,068.89 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide ENTECAVIR 0.5 MG TABLET 30S. This delivery order contract has a completion date of January 30, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) the...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJK6BDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,616.15 by the Defense Logistics Agency on January 28, 2026, for the supply of Entecavir 0.5 mg tablets (30-count packages). This firm fixed-price, competitively awarded delivery order represents a non-set-aside contract with an ultimate completion date of January 29, 2026. The award was issued under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order falls within AmerisourceBergen's extensive portfolio of federal medical procurement services, which includes prescription medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The Defense Logistics Agency, operating under the Department of Defense, utilizes such pharmaceutical supply contracts to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. AmerisourceBergen's consistent receipt of competitively awarded contracts demonstrates its capability to meet stringent federal procurement requirements and deliver critical pharmaceutical commodities efficiently to government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/27/26 |